AU
UK
CA
NZ
IND
US
Lianhe Sowell International Group (NASDAQ: LHSW) made its Nasdaq debut on April 3, 2025, raising $8 million in gross proceeds. The company specializes in machine vision solutions, incorporating advanced technologies such as image processing, sound imaging, and video analysis. Lianhe Sowell's key innovations include …
Mesoblast (Nasdaq: MESO) has confirmed that its allogeneic cellular products, including Ryoncil® and Revascor®, will be exempt from U.S. tariffs. This exemption is made possible because the company’s products are designated as “U.S. Country of Origin” products. All products are manufactured using U.S. donors …
Telix Pharmaceuticals (ASX/NASDAQ: TLX) has appointed Anne Whitaker as a Non-Executive Director, effective April 7, 2025. Whitaker's appointment brings a wealth of knowledge and experience to the company, stemming from over three decades in the pharmaceutical, biotech, and specialty pharmaceutical sectors.
Index Update
Phase III ALIGN Study:Approval is based on interim data from a clinical trial showing proteinuria reduction at 36 weeks. Full results, including kidney function impact, are expected in 2026.
Revenue Decline:Sales fell 5% to $2.372 billion, but still topped forecasts of $2.33 billion.
Stock Drops:J&J shares fell 7.6%, closing at $153.25, marking a sharp reversal from its recent breakout.
Global Decline:Sales dropped49% in China (Feb), 76.3% in Germany (Feb), and 2% in the U.S. (Jan-Feb).
High Demand Expected:The originalSwitch sold nearly 151 million units, making it Nintendo’sbest-selling home consoleever.
Please wait processing your request...